How much funding is available in total?

$5,900,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.

FederalOpenFixed dateNational Institutes of Health

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Award ceiling: up to $300,000
Closes: Nov 10, 2026
Last verified: 2026-09-06

Awards up to $300,000 per recipient for business, nonprofit, other legal entity, public agency, tribal government, closing Nov 10, 2026.

Official page Sign in to trackVerified2026-09-06

BusinessNonprofitOther Legal EntityPublic AgencyTribal GovernmentHealth & Human Services

In one sentence

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) awards up to $300,000 per recipient, open to business, nonprofit, other legal entity, public agency, tribal government, closing Nov 10, 2026.

Record fields

Program pool (total): $5,900,000
Total across all awards in this programme. Not an amount any single applicant can receive.
Award ceiling (per project): $300,000
Award floor: Not confirmed
Typical award: Not confirmed
Deadline: Nov 10, 2026
Deadline type: Fixed date
Opens: Jun 3, 2026
Status: Open
Eligible entities: Business · Nonprofit · Other Legal Entity · Public Agency · Tribal Government
Geography: Not stated
Matching funds: Not confirmed
Disbursement: Not confirmed
Application effort: Not confirmed
Use of funds: development of technologies for molecular or cellular characterization of cancer · improved handling and quality control of biospecimens · technical validation of emerging technologies
Currency: USD

How much money is available?

Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.

Program pool (total)Across all awards this cycle

$5,900,000

Award ceiling (per project)The most one applicant can receive

$300,000

Who can apply?

level

federal

Derived from the source that published this record

entity

Business, Nonprofit, Other Legal Entity, Public Agency, Tribal Government

Source field: entity types

industry

Health & Human Services

Source field: industries

use

development of technologies for molecular or cellular characterization of cancer, improved handling and quality control of biospecimens, technical validation of emerging technologies

Source field: use of funds

size limit

Not confirmed

Source field: applicant size limit

clause text

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.

When does it close?

Nov 10, 202664 daysDeadline type Fixed date

What can the money be used for?

3 categorysThe source’s own spending categories, and what is not parsed.

development of technologies for molecular or cellular characterization of cancerimproved handling and quality control of biospecimenstechnical validation of emerging technologies

These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.

What comparable notices state

333 recordsStated ceilings on open records in the same industry.

Among open records stored under Health & Human Services, 333 of 928 state an award ceiling. Those that do run:

25th percentile$250,000
Median$500,000
75th percentile$1,200,000

A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.

Common questions

5 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.

How much can one applicant receive?: Up to $300,000 per recipient.
How much funding is available in total?: $5,900,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
When is the application deadline?: Nov 10, 2026.
Who is eligible to apply?: Business, Nonprofit, Other Legal Entity, Public Agency, Tribal Government.
What can the funding be used for?: development of technologies for molecular or cellular characterization of cancer, improved handling and quality control of biospecimens, technical validation of emerging technologies, as classified by the source.

AI summary of the source text

Optional. Every core field on this record is already above, free and complete.

AI summary of the source text

Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.

Included with Studio

Provenance

Source pagegrants.gov

Retrieved2026-09-06

MethodAutomated check

First seen2026-09-02

The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.